Metraipolis › archive › dc_684badfe4114
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities — Europe PMC PMID:40937192
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40937192
- DOI
- 10.1002/mco2.70383
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T01:19:33.889Z
- SHA-256 of the archived text
8c8b60d37a7766d306a16e867cebb0cdfdce4ba31eb04da07b5c94459369896a- Stable URL of this page
https://metraipolis.com/documento/dc_684badfe4114
How to cite
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities — Europe PMC PMID:40937192 — Europe PMC (en), https://europepmc.org/article/MED/40937192 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_684badfe4114 (Metraipolis archive dc_684badfe4114, sha256 8c8b60d37a7766d306a16e867cebb0cdfdce4ba31eb04da07b5c94459369896a)
BibTeX
@misc{dc684badfe4114,
title = {Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities — Europe PMC PMID:40937192},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40937192},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_684badfe4114; sha256 8c8b60d37a7766d306a16e867cebb0cdfdce4ba31eb04da07b5c94459369896a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40937192. Agents can read the archived copy with the MCP tool read_document.